Research Advances and Therapeutic Potential of Gut Microbiota in Metabolic Diseases
Shuyu Yuan1,#, Guoxiao Han1,#, Huimin Qiu1, Henan Zheng2, Rongzhi Fang1, Wangmiao Xie1, Wangui Yu1,*, Xiaochun Peng1,*
BIOCELL, Vol.50, No.4, 2026, DOI:10.32604/biocell.2026.075338
- 21 April 2026
(This article belongs to the Special Issue: Cellular and Molecular Mechanisms of Gut Microbiota, Oxidative Stress, and Inflammation in Health and Disease)
Abstract The gut microbiota plays a pivotal role in maintaining host metabolic homeostasis. Accumulating evidence has demonstrated that dysbiosis of the gut microbiota is closely associated with metabolic disorders, including obesity, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD). These alterations affect energy harvest, bile acid and short-chain fatty acid metabolism, intestinal barrier integrity, and low-grade inflammation, thereby contributing to insulin resistance and ectopic fat accumulation. In this narrative review, we summarize current knowledge on microbiome-host interactions in metabolic diseases, with a focus on energy metabolism, immune regulation, and inflammatory pathways. We further More >
Graphic Abstract